IDEAS logo
IDEAS-lightbulb

IDEAS welcomes AstraZeneca to our H2020 project

IDEAS would like to welcome AstraZeneca to our innovative training network as a partner.

Project spotlight:

2. Pooling information on progression-free and overall survival in multi-arm cancer trials

Progression-free survival is often used as a surrogate endpoint for overall survival in early phase trials of cancer treatments.

[ see all projects ]